AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Piroever Tablet DT

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Piroxicam (20mg)

Overview Piroever Tablet DT

Piroever DT tablets offer relief from moderate to severe pain. Indicated for conditions like osteoarthritis and rheumatoid arthritis, they alleviate joint and muscle pain and inflammation. Administer Piroever DT with food to minimize stomach upset. Dosage and treatment length vary depending on individual response and condition. Continue taking the medication as prescribed, even after symptom improvement, until your physician advises otherwise. Common side effects include nausea, vomiting, stomach discomfort, headache, and dizziness. Report persistent or worsening side effects to your doctor, who can offer management strategies. Prior to use, disclose any history of stomach ulcers, cardiovascular disease, hypertension, or liver/kidney impairment to your doctor. Similarly, inform your doctor of all other medications you are currently using, as interactions are possible. Pregnant or breastfeeding individuals should seek medical counsel before using Piroever DT.

Uses of Piroever Tablet DT

Analgesia

Major Benefits of Piroever Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Piroever DT tablet in water before consumption. It should be administered with a meal.

Common Side effects of Piroever Tablet DT:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Piroever Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Piroever Tablet DT in water before consumption; it should be taken with meals.

How Piroever Tablet DT works:

DT Piroever tablets contain a non-steroidal anti-inflammatory drug that inhibits the production of inflammatory mediators, thus alleviating pain and swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Piroever DT tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Piroever Tablet DT is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Piroever Tablet DT while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, blurred vision, dizziness, or reduced alertness after taking Piroever Tablet DT.

KidneyKidneyCAUTION

Patients with significant renal impairment should use Piroever Tablet DT with close monitoring. Dosage modification of Piroever Tablet DT may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Piroever Tablet DT, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Piroever Tablet DT :

Should you forget a Piroever Tablet DT dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Piroever Tablet DT

LabelValue
Type of Compound Esters of enolic acids
Addictive None.
Type of Medication Pain relievers

FAQs on Piroever Tablet DT

Piroxicam, the active ingredient in Piroever Tablet DT, and diclofenac are both analgesics. Unlike diclofenac, which exhibits some preference for COX-2, piroxicam non-selectively inhibits cyclooxygenase enzymes (COX-1 and COX-2), responsible for inflammation and pain. This selective action of diclofenac is believed to reduce adverse effects relative to Piroever Tablet DT.
Naproxen and Piroever Tablet DT are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects relative to Piroever Tablet DT.
Piroever Tablet DT and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse events than Piroever Tablet DT.
Piroever Tablet DT and ketoprofen are both analgesics, non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain sensation. Clinical trials indicate superior efficacy of topical ketoprofen gel relative to Piroever Tablet DT. Furthermore, ketoprofen gel demonstrated excellent patient tolerability.
Piroxicam (in Piroever DT tablets) targets COX enzymes, key players in inflammatory and pain processes, while tramadol offers analgesic relief through a narcotic-like mechanism. Tramadol carries a risk of dependence.
Piroxicam (as found in Piroever Tablet DT) and nimesulide are both analgesics. Unlike nimesulide, which selectively targets COX-2, piroxicam inhibits both COX-1 and COX-2 enzymes, impacting inflammation and pain. This selectivity in nimesulide is believed to reduce adverse reactions relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't reduce platelet levels; however, analgesics such as piroxicam increase bleeding risk. Therefore, avoid taking Piroever Tablet DT or similar pain relievers for fever accompanied by joint pain. Seek medical advice before commencing Piroever Tablet DT.
Piroever Tablet DT and aspirin are distinct medications, although both are classified as COX (cyclooxygenase) inhibitors. Their shared properties include anti-inflammatory and analgesic effects.
Concurrent use of Piroever Tablet DT and dexamethasone is contraindicated due to their synergistic toxicity, significantly elevating the likelihood of gastrointestinal ulceration.
Concurrent use of methocarbamol and Piroever Tablet DT is considered safe, lacking documented significant adverse interactions. However, physician consultation prior to initiating either treatment is recommended.
Paracetamol's concurrent use with Piroever DT tablets is considered safe, lacking known severe adverse reactions. Consult your physician prior to commencing either treatment.
Affirmative. Piroever DT tablets are classified as a non-steroidal anti-inflammatory medication.
Piroever DT tablets contain sulfur. Use of Piroever DT tablets may trigger serious side effects in susceptible patients, including severe dermatological reactions such as Stevens-Johnson syndrome. Allergy disclosure to your physician is essential.
Piroever DT tablets do not possess anticoagulant properties; they are analgesics. Patients with hemorrhagic conditions should refrain from using this medication.
Piroever DT tablets do not relax muscles. They are analgesics that inhibit COX enzymes, thereby reducing inflammation and pain.
Piroever DT tablets do not contain narcotics. This analgesic targets the COX enzyme (cyclooxygenase), an enzyme involved in inflammation and pain signaling, to reduce both pain and inflammation.
Piroever Tablet DT does not treat high blood pressure. Concurrent use with antihypertensive drugs reduces their efficacy. Always disclose your use of antihypertensive medications to your physician prior to commencing Piroever Tablet DT.
Concomitant use of Piroever Tablet DT and losartan is contraindicated. Piroever Tablet DT diminishes the efficacy of losartan and similar antihypertensive agents, potentially resulting in treatment failure. Disclose current antihypertensive medication use to your physician prior to initiating Piroever Tablet DT therapy.
Concurrent use of Piroever Tablet DT and lisinopril is contraindicated. Piroxicam, the active ingredient in Piroever Tablet DT, diminishes the efficacy of antihypertensive drugs such as lisinopril, potentially rendering antihypertensive treatment ineffective. Disclose any current antihypertensive medication use to your physician prior to commencing Piroever Tablet DT.
Confirmed. Concurrent use of Piroever Tablet DT and calcium channel blockers is acceptable. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may lessen the efficacy of most antihypertensive medications, with calcium channel blockers representing an exception (White, 2007).
Piroever DT tablets may be used concurrently with tizanidine. Piroxicam, an analgesic, and the skeletal muscle relaxant tizanidine are compatible; this combination is suitable for conditions such as back pain.
Affirmative. Concomitant administration of Piroever Tablet DT and beta-cyclodextrin is feasible. Studies indicate this combination accelerates piroxicam's therapeutic effect and mitigates gastrointestinal adverse reactions.
Affirmative. Piroxicam tablets have comparable medications. Analgesics are selected based on the specific illness. Physician consultation is advised before commencing piroxicam therapy or switching treatments.
Piroxicam should not be used in patients with allergies to the drug, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney dysfunction.
Piroever Tablet DT does not alleviate allergic reactions; it is an analgesic.
Piroxicam extended-release tablets provide prolonged pain relief with a single daily dose. However, individual responses vary, and the analgesic effect of piroxicam generally improves with continued use over several weeks.
Piroever DT tablets are not associated with elevated blood pressure. This medication is a non-narcotic analgesic.
Delayed-release piroxicam tablets are not indicated for dysmenorrhea. Clinical trials demonstrate piroxicam's substantial efficacy in mitigating menstrual pain.
Piroever Tablet DT lacks regulatory approval for migraine management. However, research indicates its efficacy in substantially reducing migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's assessment to determine the underlying cause of your back pain is crucial before commencing treatment. Avoid self-prescribing Piroever Tablet DT, as the etiology of back pain varies individually.
Piroever Tablet DT is an appropriate treatment option for acute gout. Clinical trials demonstrate its high efficacy in managing acute gout attacks.
Blood donation is permissible while taking Piroever Tablet DT; however, it's crucial to consult your physician beforehand.
In diabetic individuals, Piroxicam DT tablets should be used solely under medical supervision. Prolonged use of this medication carries a significant risk of kidney failure. Since diabetes is an independent risk factor for kidney disease, adding piroxicam substantially increases this risk.
Individuals with impaired kidney function should avoid Piroever Tablet DT. Prolonged use of NSAIDs is linked to kidney damage, including papillary necrosis.
Skin reactions, potentially severe and even life-threatening, are a known side effect of Piroever Tablet DT. These include exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Serious reactions can develop unexpectedly. Report any rash, even a mild one, to your physician and stop taking the medication immediately.
Piroever DT tablets are contraindicated during pregnancy. Their use is associated with premature ductus arteriosus closure, potentially resulting in fetal cardiac failure and mortality.
Piroever Tablet DT is not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and bleeding.
Individuals with asthma may experience heightened sensitivity to non-steroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to commencing this type of treatment.
Affirmative. Piroever Tablet DT may induce temporary infertility in some individuals. Piroxicam's pharmacological properties can potentially impede or inhibit ovarian follicle rupture, a factor linked to reversible infertility. Physician consultation prior to commencing treatment is advisable.
Piroever Tablet DT is contraindicated for concurrent use with diuretics. In certain individuals, Piroever Tablet DT diminishes the sodium-excreting action of furosemide and thiazide diuretics. This interaction is believed to result from the suppression of renal prostaglandin production.
Piroever Tablet DT and lithium are contraindicated. Concurrent use of Piroever Tablet DT elevates plasma lithium concentrations and diminishes lithium's renal clearance. This effect stems from the NSAID's inhibition of renal prostaglandin production. Physician consultation is mandatory prior to commencing Piroever Tablet DT therapy.
Concomitant use of Piroever Tablet DT and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician prior to Piroever Tablet DT administration. If co-administered, close clinical observation is mandatory.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age also contribute to increased ulcer risk.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics before or following cardiac bypass surgery.
Gastrointestinal distress, and in uncommon instances, severe gastrointestinal adverse events including peptic ulcers and hemorrhage, along with serious dermatological reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis, hepatic failure, and kidney injury.
Piroever Tablet DT
101
MRP 123
17% off